p53 activation by Cr(VI): a transcriptionally limited response induced by ATR kinase in S-phase

Toxicological Sciences : an Official Journal of the Society of Toxicology
Michal W LuczakAnatoly Zhitkovich

Abstract

Cellular reduction of carcinogenic chromium(VI) causes several forms of Cr-DNA damage with different genotoxic properties. Chromate-treated cultured cells have shown a strong proapoptotic activity of the DNA damage-sensitive transcription factor p53. However, induction of p53 transcriptional targets by Cr(VI) in rodent lungs was weak or undetectable. We examined Cr(VI) effects on the p53 pathway in human cells with restored levels of ascorbate that acts as a principal reducer of Cr(VI) in vivo but is nearly absent in standard cell cultures. Ascorbate-restored H460 and primary human cells treated with Cr(VI) contained higher levels of p53 and its Ser15 phosphorylation, which were induced by ATR kinase. Cr(VI)-stimulated p53 phosphorylation occurred in S-phase by a diffusible pool of ATR that was separate from the chromatin-bound pool targeting DNA repair substrates at the sites of toxic mismatch repair of Cr-DNA adducts. Even when more abundantly present than after exposure to the radiomimetic bleomycin, Cr(VI)-stabilized p53 showed a much more limited activation of its target genes in two types of primary human cells. No increases in mRNA were found for nucleotide excision repair factors and a majority of proapoptotic genes. A ...Continue Reading

References

May 1, 1991·Environmental Health Perspectives·M Costa
Mar 1, 1994·Chemical Research in Toxicology·D M Stearns, K E Wetterhahn
Nov 5, 1997·Biochemical and Biophysical Research Communications·K KondoY Monden
Feb 7, 1998·Genes & Development·J D SilicianoM B Kastan
May 2, 2000·Toxicological Sciences : an Official Journal of the Society of Toxicology·D L CarlisleS R Patierno
Jul 14, 2000·American Journal of Industrial Medicine·H J GibbB C Rooney
Mar 1, 2002·Molecular Carcinogenesis·Toshiyuki HiroseYasumasa Monden
May 29, 2003·Occupational and Environmental Medicine·R S LuippoldD Proctor
Nov 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Heidrun Ellinger-ZiegelbauerHans-Jurgen Ahr
Jan 18, 2005·Chemical Research in Toxicology·Anatoly Zhitkovich
Apr 16, 2005·Molecular and Cellular Biology·Elizabeth Peterson-RothAnatoly Zhitkovich
Sep 17, 2005·American Journal of Respiratory Cell and Molecular Biology·Patrizia RussoLorenzo Dominioni
Nov 12, 2005·Molecular and Cellular Biochemistry·Travis J O'BrienSteven R Patierno
May 24, 2006·Free Radical Biology & Medicine·Joseph MesserAnatoly Zhitkovich
May 15, 2007·Toxicology and Applied Pharmacology·Ahmed N UddinMax Costa
Nov 1, 2007·Chemical Research in Toxicology·Konstantin Salnikow, Anatoly Zhitkovich
Nov 13, 2008·The Journal of Biological Chemistry·Susumu RokudaiIssay Kitabayashi
May 20, 2009·Cell·Jan-Philipp Kruse, Wei Gu
Nov 3, 2009·Chemical Research in Toxicology·Andrea MacfieAnatoly Zhitkovich
Feb 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaoyong FuYi Wang
Oct 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Chul Won LeePeter E Wright
Oct 23, 2010·Science·Zhi GuoTanya T Paull
Apr 10, 2013·Toxicology and Applied Pharmacology·Victor C WongAnatoly Zhitkovich
Jan 1, 1996·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·A ZhitkovichP Toniolo

❮ Previous
Next ❯

Citations

Oct 2, 2020·Chemical Research in Toxicology·Anatoly Zhitkovich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.